MedTrace Logo

General Tissue Response Classification System After Chemotherapy

NCT03791268 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2019-01-02

No results posted yet for this study

Summary

This research intend to collect the information of gastric cancer patients who received preoperative neoadjuvant chemotherapy and radical gastric ectomy at Department of Gastrointestinal Surgery, West China Hospital, Sichuan University. Base on The degree of edema, intraoperative effusion, fibrosis of connecting tissues, the investigators aim to constitute the core parameters of the tissue response grading system following neoadjuvant chemotherapy, and explore the mutual effect among the tissue response grading system, tumor regression response and long-term survival outcome of tumor patients.

Conditions

  • Stomach Adenocarcinoma

Interventions

PROCEDURE

Gastric cancer surgery

Gastric cancer surgery is performed according to the Japanese Guidelines. Patients will intraoperative evaluate the edema, fibrosis and exudation.

Sponsors & Collaborators

  • West China Hospital

    lead OTHER

Principal Investigators

  • Jian-Kun Hu, MD, PhD · West China Hospital

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03791268 on ClinicalTrials.gov